Your session is about to expire
← Back to Search
Behavioural Intervention
Gamified Intervention for Alzheimer's Disease
N/A
Waitlist Available
Led By Stuart Zola
Research Sponsored by MapHabit, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Individual diagnosed with Alzheimer's disease or other related dementia (ADRD) in their mild to moderate stage of impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-post: the assessment was administered at the beginning and end of the study's duration (6-month study).
Awards & highlights
Study Summary
This trialwill test a gamified system to help people with dementia and their care partners improve their quality of life and reduce burden. 40 individuals and their care partners will be studied for 6 months.
Eligible Conditions
- Alzheimer's Disease
- Dementia
- Gamification
- Assistive Technology
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have been diagnosed with Alzheimer's disease or a related form of dementia and your symptoms are in the early to middle stages.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-post: the assessment was administered at the beginning and end of the study's duration (6-month study).
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-post: the assessment was administered at the beginning and end of the study's duration (6-month study).
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL) from baseline at 6 months
Change in Margaret Blenkner Research Center (MBRC) Caregiver Strain instrument from baseline at 6 months
Change in User Interaction and Engagement from baseline at 6 months
+1 moreSecondary outcome measures
2-item Satisfaction Scale (SS-2)
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Gamified InterventionExperimental Treatment1 Intervention
This condition will involve the implementation of an assistive technology software (named the MapHabit system) with added gamification features into the daily care of individuals with mild to moderate stage of dementia. The MapHabit System (MHS) is a commercially available visual mapping software application that utilize visual, audio, and text media to create step-by-step visual guides to assist individuals and their caregivers in structuring and accomplishing activities of daily living (ADLs). The application will be made available to families through compatible tablets.
Group II: Exploratory InterventionExperimental Treatment1 Intervention
The exploratory condition will be given the same MHS version as the active comparator (control condition). However, for this group, participants will also engage in virtual reality games throughout the duration of the study. These virtual reality games are integrated with the MHS and includes cognitive games revolving around mental acuity, motor skills, etc.
Group III: Non-gamified InterventionActive Control1 Intervention
This control condition acted as the active comparator to the experimental condition. The same assistive technology, the MapHabit system, will be given to a separate group of participants. The difference here will be that the software will be a version that does not include gamification features.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
The MapHabit system
2022
N/A
~50
Find a Location
Who is running the clinical trial?
MapHabit, Inc.Lead Sponsor
3 Previous Clinical Trials
92 Total Patients Enrolled
VirtuleapUNKNOWN
Stuart ZolaPrincipal InvestigatorMapHabit, Inc.
1 Previous Clinical Trials
50 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must be able to communicate in English.You do not understand English well enough to participate.You have been diagnosed with Alzheimer's disease or a related form of dementia and your symptoms are in the early to middle stages.You do not have Alzheimer's disease or related dementia.You have mild to moderate Alzheimer's disease or other related memory impairment.
Research Study Groups:
This trial has the following groups:- Group 1: Non-gamified Intervention
- Group 2: Gamified Intervention
- Group 3: Exploratory Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still slots available for individuals to join this research project?
"Affirmative. According to clinicaltrials.gov, this medical trial, which first became available on September 12th 2022, is presently seeking out participants. Approximately 45 individuals must be enrolled from the sole location offering it."
Answered by AI
How many persons are participating in this experiment?
"Affirmative. According to the data on clinicaltrials.gov, this medical research has been actively recruiting since September 12th of 2022 and is currently seeking 45 participants from a single location."
Answered by AI
Who else is applying?
What state do they live in?
Georgia
What site did they apply to?
MapHabit
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger